Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
vermicon is a Munich-based biotechnology company specializing in the rapid identification and analysis of microorganisms using advanced molecular biology techniques. The company's core competency lies in its proprietary VIT (vermicon identification technology), which utilizes Fluorescence In Situ Hybridization (FISH) to detect living microorganisms directly in samples without the need for cultivation. vermicon provides a wide range of diagnostic kits and services for sectors including wastewater treatment, food and beverage production, and clinical diagnostics. Their solutions enable faster decision-making by providing highly specific and quantifiable results on microbial populations. The company also offers contract research services for customized microbial analysis and monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on vermicon.